Hikma Pharmaceutical | HIK - Market Capitalization


Hikma Pharmaceutical reported $3.65B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.3B 150.98M Nov/2026
argenx SE USD 60.01B 2.38B Sep/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
Fresenius EUR 28.97B 3.77B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Recordati EUR 10.93B 82.06M Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
UCB EUR 46.41B 13.94B Dec/2025